ResMed initiated with an Overweight at Morgan Stanley
Morgan Stanley analyst David Bailey initiated coverage of ResMed (RMD) with an Overweight rating and $280 price target The ...
Nasdaq5 天
Is ResMed Stock Outperforming the Dow?
With a market cap of $32.6 billion, San Diego, California-based ResMed Inc. (RMD) is a global leader in designing, manufacturing, and distributing medical devices and cloud-based software ...